Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Quaranta

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Scientific Reports|July 20, 2017
A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast CancerMatthew T McKenna, Jared A Weis, Stephanie L Barnes, et al.
Science Translational Medicine|May 31, 2013
Clinically relevant modeling of tumor growth and treatment responseThomas E Yankeelov, Nkiruka Atuegwu, David Hormuth, et al.
Engineering with Computers|December 2, 2024
A global sensitivity analysis of a mechanistic model of neoadjuvant chemotherapy for triple negative breast cancer constrained by in vitro and in vivo imaging dataGuillermo Lorenzo, Angela M Jarrett, Christian T Meyer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 8, 2016
Altered TGF-α/β signaling drives cooperation between breast cancer cell populationsOmar E Franco, Darren R Tyson, Katherine C Konvinse, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Heterogeneous, population-level drug-tolerant persisters exhibit ion-channel remodeling and ferroptosis susceptibilityCorey E Hayford, Blake Baleami, Philip E Stauffer, et al.
Nature Methods|May 3, 2016
An unbiased metric of antiproliferative drug effect in vitroLeonard A Harris, Peter L Frick, Shawn P Garbett, et al.
Plos Computational Biology|November 1, 2019
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizersDavid J Wooten, Sarah M Groves, Darren R Tyson, et al.
Cancer Research|March 3, 2019
Correction: Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor HeterogeneityAkshata R Udyavar, David J Wooten, Megan Hoeksema, et al.
Biophysical Journal|July 21, 2010
Bimodal analysis reveals a general scaling law governing nondirected and chemotactic cell motilityJ Scott Gruver, Alka A Potdar, Junhwan Jeon, et al.
Scientific Reports|February 17, 2017
Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF InhibitionKeisha N Hardeman, Chengwei Peng, Bishal B Paudel, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Scientific Reports|July 20, 2017
A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast CancerMatthew T McKenna, Jared A Weis, Stephanie L Barnes, et al.
Science Translational Medicine|May 31, 2013
Clinically relevant modeling of tumor growth and treatment responseThomas E Yankeelov, Nkiruka Atuegwu, David Hormuth, et al.
Engineering with Computers|December 2, 2024
A global sensitivity analysis of a mechanistic model of neoadjuvant chemotherapy for triple negative breast cancer constrained by in vitro and in vivo imaging dataGuillermo Lorenzo, Angela M Jarrett, Christian T Meyer, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 8, 2016
Altered TGF-α/β signaling drives cooperation between breast cancer cell populationsOmar E Franco, Darren R Tyson, Katherine C Konvinse, et al.
Biorxiv : the Preprint Server for Biology|April 27, 2026
Heterogeneous, population-level drug-tolerant persisters exhibit ion-channel remodeling and ferroptosis susceptibilityCorey E Hayford, Blake Baleami, Philip E Stauffer, et al.
Nature Methods|May 3, 2016
An unbiased metric of antiproliferative drug effect in vitroLeonard A Harris, Peter L Frick, Shawn P Garbett, et al.
Plos Computational Biology|November 1, 2019
Systems-level network modeling of Small Cell Lung Cancer subtypes identifies master regulators and destabilizersDavid J Wooten, Sarah M Groves, Darren R Tyson, et al.
Cancer Research|March 3, 2019
Correction: Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor HeterogeneityAkshata R Udyavar, David J Wooten, Megan Hoeksema, et al.
Biophysical Journal|July 21, 2010
Bimodal analysis reveals a general scaling law governing nondirected and chemotactic cell motilityJ Scott Gruver, Alka A Potdar, Junhwan Jeon, et al.
Scientific Reports|February 17, 2017
Dependence On Glycolysis Sensitizes BRAF-mutated Melanomas For Increased Response To Targeted BRAF InhibitionKeisha N Hardeman, Chengwei Peng, Bishal B Paudel, et al.
Pageof 12